High Growth IM8 IM8 revenue and ARR momentum present a compelling cross-sell opportunity from Prenetics core biotech offerings to established consumer health buyers. Engage with IM8 success stories to position premium longevity products to retailers and DTC partners seeking proven growth narratives.

Strategic Partnerships Board additions and high-profile brand co-founders (Beckham, Sabalenka, Leogrande) signal strong governance and marketing muscle. Leverage these connections to unlock co-branding deals, influencer-driven campaigns, and strategic distribution partnerships in health and wellness verticals.

Expansion Roadmap Upcoming SKUs across Hydration, Creatine, and Kids' Gummies indicate product line expansion and broader consumer targets. Explore distribution in fitness, family wellness, and sports nutrition channels, and position as a one-stop longevity brand for retailers seeking portfolio diversification.

Global ARR Levers IM8 reached significant ARR milestones and is projected to scale further. Target enterprise and DTC partnerships in new markets, license or white-label opportunities, and strategic investments to accelerate international growth and channel diversification.

Operational Readiness Recent leadership additions to finance and governance alongside profitable quarterly results imply a solid foundation for formal enterprise sales discussions, including channel partnerships, co-manufacturing, and tiered wholesale agreements with clear profitability guidance.